347 related articles for article (PubMed ID: 6249851)
1. Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.
Seligmann BE; Gallin JI
J Clin Invest; 1980 Sep; 66(3):493-503. PubMed ID: 6249851
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
Fletcher MP; Stahl GL; Longhurst JC
J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
[TBL] [Abstract][Full Text] [Related]
3. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
Seligmann BE; Fletcher MP; Gallin JI
J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
Fletcher MP; Seligmann BE; Gallin JI
J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
[TBL] [Abstract][Full Text] [Related]
5. Degranulating stimuli decrease the neagative surface charge and increase the adhesiveness of human neutrophils.
Gallin JI
J Clin Invest; 1980 Feb; 65(2):298-306. PubMed ID: 6243307
[TBL] [Abstract][Full Text] [Related]
6. Comparison of indirect probes of membrane potential utilized in studies of human neutrophils.
Seligmann BE; Gallin JI
J Cell Physiol; 1983 May; 115(2):105-15. PubMed ID: 6302103
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease.
Ahlin A; Gyllenhammar H; Ringertz B; Palmblad J
J Lab Clin Med; 1995 Mar; 125(3):392-401. PubMed ID: 7897306
[TBL] [Abstract][Full Text] [Related]
8. Studies in normal and chronic granulomatous disease neutrophils indicate a correlation of tubulin tyrosinolation with the cellular redox state.
Nath J; Gallin JI
J Clin Invest; 1983 May; 71(5):1273-81. PubMed ID: 6406545
[TBL] [Abstract][Full Text] [Related]
9. Gold complexes and activation of human polymorphonuclear leukocytes. Dissociation of changes in membrane potential and oxidative burst.
Rudkowski R; Ziegler JB; Graham GG; Joulianos G
Biochem Pharmacol; 1992 Sep; 44(6):1091-8. PubMed ID: 1417933
[TBL] [Abstract][Full Text] [Related]
10. Modulation of neutrophil-reduced pyridine nucleotide content following stimulation with phorbol myristate acetate and chemotactic factors.
Van Epps DE; Bender JG; Steinkamp JA; Chenoweth DE
J Leukoc Biol; 1985 Nov; 38(5):587-601. PubMed ID: 2995525
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
Ahlin A; Elinder G; Palmblad J
Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of equine neutrophils in response to calcium ionophore A23187 and phorbol myristate acetate ex vivo.
Moore T; Wilcke J; Chilcoat C; Eyre P; Crisman M
Vet Immunol Immunopathol; 1997 May; 56(3-4):233-46. PubMed ID: 9223228
[TBL] [Abstract][Full Text] [Related]
13. Interaction of chemotactic factors with human polymorphonuclear leukocytes: studies using a membrane potential-sensitive cyanine dye.
Seligmann BE; Gallin EK; Martin DL; Shain W; Gallin JI
J Membr Biol; 1980; 52(3):257-72. PubMed ID: 6770097
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential.
Seligmann B; Chused TM; Gallin JI
J Clin Invest; 1981 Nov; 68(5):1125-31. PubMed ID: 7298844
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
16. Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenylalanine: role of excited oxygen species.
Masuda M; Komiyama Y; Murakami T; Murata K; Hasui M; Hirabayashi Y; Kobayashi Y
J Leukoc Biol; 1990 Feb; 47(2):105-10. PubMed ID: 2303745
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.
Van Epps DE; Garcia ML
J Clin Invest; 1980 Aug; 66(2):167-75. PubMed ID: 6249846
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome b translocation to human neutrophil plasma membranes and superoxide release. Differential effects of N-formylmethionylleucylphenylalanine, phorbol myristate acetate, and A23187.
Ohno Y; Seligmann BE; Gallin JI
J Biol Chem; 1985 Feb; 260(4):2409-14. PubMed ID: 2982817
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
English D; Lukens JN
J Immunol; 1983 Feb; 130(2):850-6. PubMed ID: 6294178
[TBL] [Abstract][Full Text] [Related]
20. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
